YOUR BUSINESS AUTHORITY
Springfield, MO
Eli Lilly had better-than-expected results in the second quarter amid higher sales of Zepbound and Mounjaro.
Adjusted earnings per share were $3.92. Analysts expected $2.60 per share.
Revenue was reported at $11.3 billion. Analysts were looking for $9.9 billion.
Read more from CNBC.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Eric Schmitt introduces Modern Skies Act
Caterpillar to acquire John Fabick Tractor Co.
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach